Invention Grant
- Patent Title: Pyridazinones as DAAO enzyme inhibitors
-
Application No.: US14652484Application Date: 2013-12-17
-
Publication No.: US09750748B2Publication Date: 2017-09-05
- Inventor: William Farnaby , Charlotte Fieldhouse , Katherine Hazel , Catrina Kerr , Natasha Kinsella , David Livermore , Kevin Merchant , David Miller
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Priority: GB1222711.2 20121217
- International Application: PCT/GB2013/000552 WO 20131217
- International Announcement: WO2014/096757 WO 20140624
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D405/04 ; A61K31/501 ; C07D403/04 ; C07D237/20 ; C07D401/04 ; A61K45/06 ; A61K31/50 ; C07D237/16 ; C07D237/22 ; A61K31/277 ; A61K31/496 ; A61K31/519 ; A61K31/53 ; A61K31/551 ; A61K31/554 ; A61K33/00
Abstract:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Public/Granted literature
- US20150329495A1 PYRIDAZINONES AS DAAO ENZYME INHIBITORS Public/Granted day:2015-11-19
Information query
